These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4025717)
1. Coronary artery vasoconstriction and its treatment with calcium channel blockers. Shapiro W Ala J Med Sci; 1985 Jul; 22(3):271-4. PubMed ID: 4025717 [No Abstract] [Full Text] [Related]
2. Selected pharmacological properties of calcium channel blockers. Sobel BE Ala J Med Sci; 1985 Jul; 22(3):274-80. PubMed ID: 2862807 [No Abstract] [Full Text] [Related]
4. Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease. Hung MJ; Cherng WJ; Cheng CW; Yang NI Am J Cardiol; 2005 Jan; 95(1):84-7. PubMed ID: 15619396 [TBL] [Abstract][Full Text] [Related]
5. [Calcium antagonists. Concept and therapeutic applications]. Eichelbaum M Med Welt; 1982 Aug; 33(31-32):1079-82. PubMed ID: 6890137 [No Abstract] [Full Text] [Related]
6. Coronary artery spasm. Mechanisms and clinical relevance. Braunwald E JAMA; 1981 Oct 23-30; 246(17):1957-9. PubMed ID: 7288977 [No Abstract] [Full Text] [Related]
7. [The role of calcium antagonists on coronary artery spasm and prevention of restenosis after angioplasty]. Kocurek A; Piwowarska W Przegl Lek; 1997; 54(1):37-42. PubMed ID: 9190633 [TBL] [Abstract][Full Text] [Related]
8. Coronary artery spasm--pathophysiology, clinical presentations, diagnostic approaches and rational treatment. Ginsburg R; Schroeder JS; Harrison DC West J Med; 1982 May; 136(5):398-410. PubMed ID: 6125054 [No Abstract] [Full Text] [Related]
12. Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities. Braun LT Heart Lung; 1983 May; 12(3):226-32. PubMed ID: 6551368 [TBL] [Abstract][Full Text] [Related]
13. [Calcium antagonists in the treatment of coronary heart disease]. Rafflenbeul W Fortschr Med; 1984 Jul; 102(27-28):718-21. PubMed ID: 6479814 [TBL] [Abstract][Full Text] [Related]
14. Clinical use of calcium entry blockers. Flaim SF; Zelis R Fed Proc; 1981 Dec; 40(14):2877-81. PubMed ID: 7308498 [TBL] [Abstract][Full Text] [Related]
15. What is optimal drug therapy in angina pectoris? Frankl WS; Brest AN Cardiovasc Clin; 1983; 13(1):209-20. PubMed ID: 6129060 [TBL] [Abstract][Full Text] [Related]
16. Coronary artery spasm: a 2009 update. Stern S; Bayes de Luna A Circulation; 2009 May; 119(18):2531-4. PubMed ID: 19433770 [No Abstract] [Full Text] [Related]
17. Calcium channel blockers. Deedwania PC West J Med; 1982 Jul; 137(1):24-31. PubMed ID: 6291255 [TBL] [Abstract][Full Text] [Related]
18. Vasospastic angina and Ca channel blockers. Minatoguchi S Curr Hypertens Rev; 2013 Aug; 9(3):219-23. PubMed ID: 24479747 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for the long-term survival in patients with vasospastic angina--analysis of effects of patients' characteristics and therapeutic drugs. Kodama S; Inoue Y; Mihara H; Sumi S; Kudo K; Okamura K; Ando C; Niimura H; Tsuchiya Y; Yamanouchi Y; Urata H J Cardiol; 2009 Aug; 54(1):10-20. PubMed ID: 19632515 [TBL] [Abstract][Full Text] [Related]